OAJ
VRTX icon

Ogorek Anthony Joseph’s Vertex Pharmaceuticals VRTX Stock Holding History

Ogorek Anthony Joseph’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38K Hold
78
– – 0.01% 215
2026
Q1 		$34K Hold
78
– – 0.01% 213
2025
Q4 		$35K Buy
78
+8
+11% +$3.45K 0.01% 197
2025
Q3 		$27K Buy
70
+2
+3% +$836 0.01% 243
2025
Q2 		$30K Sell
68
-2
-3% -$922 0.01% 211
2025
Q1 		$33K Buy
70
+31
+79% +$14.4K 0.01% 206
2024
Q4 		$15K Buy
+39
New +$18.1K ﹤0.01% 200
2024
Q3 		– Sell
-5
Closed -$2K – 291
2024
Q2 		$2K Hold
5
– – ﹤0.01% 257
2024
Q1 		$2K Buy
+5
New +$2.11K ﹤0.01% 261

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Ogorek Anthony Joseph's VRTX Position: Q2 2026 in Review

Ogorek Anthony Joseph held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 78 shares worth $38K. The position accounts for 0.01% of the portfolio, ranked #215.

Ogorek Anthony Joseph first reported a position in VRTX in Q1 2024 and has held it in 9 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Ogorek Anthony Joseph held 78 shares of Vertex Pharmaceuticals worth $38K as of Q2 2026.
  • Ogorek Anthony Joseph left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.01% of Ogorek Anthony Joseph's portfolio in Q2 2026, its #215 holding.
  • Ogorek Anthony Joseph first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Ogorek Anthony Joseph's 13F filing for Q2 2026, filed 7 Aug 2026.